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ABSTRACT
Chromosome translocations and gene fusions are
frequent events in the human genome and have
been found to cause diverse types of tumor.
ChimerDB is a knowledgebase of fusion genes
identified from bioinformatics analysis of transcript
sequences in the GenBank and various other public
resources such as the Sanger cancer genome
project (CGP), OMIM, PubMed and the Mitelman’s
database. In this updated version, we significantly
modified the algorithm of identifying fusion
transcripts. Specifically, the new algorithm is more
sensitive and has detected 2699 fusion transcripts
with high confidence. Furthermore, it can identify
interchromosomal translocations as well as the
intrachromosomal deletions or inversions of large
DNA segments. Importantly, results from the
analysis of next-generation sequencing data in the
short read archives are incorporated as well. We
updated and integrated all contents (GenBank,
Sanger CGP, OMIM, PubMed publications and
the Mitelman’s database), and the user-interface
has been improved to support diverse types of
searches and to enhance the user convenience
especially in browsing PubMed articles. We also
developed a new alignment viewer that should facil-
itate examining reliability of fusion transcripts
and inferring functional significance. We expect
ChimerDB 2.0, available at http://ercsb.ewha.ac
.kr/fusiongene, to be a valuable tool in identifying
biomarkers and drug targets.
INTRODUCTION
Fusion genes play important roles in tumorigenesis and
cancer progression (1). Perhaps, the best-characterized
case, BCR-ABL1 fusion is the cause of the chronic
myelogenous leukemia and the target of the anticancer
drug, Gleevec (imatinib) (2). Identiﬁcation of fusion
genes thus can lead to the discovery of diagnostic
biomarkers and therapeutic targets as well as understand-
ing the molecular basis of tumorigenesis.
Initial studies have concentrated on the hematological
cancer in large part due to the sample availability (1,3).
Over the last few years, however, there has been signiﬁcant
progress in fusion gene identiﬁcation in solid tumors.
Importantly, Chinnaiyan and colleagues (4–7) reported
several cases of gene fusion in prostate cancer identi-
ﬁed via integrative analysis of microarray data
(TMPRSS2 and ETS transcription factors) and
transcriptome resequencing. Soda et al. (8) identiﬁed the
transforming EML4-ALK fusion gene in nonsmall cell
lung cancer (NSCLC) using a function-based screening
procedure. A proteomic study of phosphotyrosine
kinases also revealed the ROS-ALK fusion in NSCLC
cell lines (9). These cases clearly indicate that gene fusions
play an important role in cancer development in solid
tumors.
Recent progress in next-generation sequencing (NGS)
techniques provides a tremendous opportunity for fusion
gene discovery. Notably, paired-end sequencing, now a
frequent if not standard procedure, compensates for the
short read length of NGS techniques (10). Sequencing and
analyzing whole genome or transcriptome lead to identi-
ﬁcation of many chromosomal aberrations including
translocations, ampliﬁcations and deletions. Short read
sequencing strategies were successfully applied to ﬁnd
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(5,11–13).
There have been considerable eﬀorts to make a catalog
of fusion genes. The Mitelman’s database and the Sanger
cancer genome project (CGP) are the notable examples of
collecting fusion genes from literature reports (1,3). The
COSMIC and CancerGenes database include other
types of chromosomal aberrations such as mutations,
ampliﬁcations and deletions (14,15). Currently, the
Mitelman’s database and the Sanger CGP collection
include 150 and 270 gene pairs, respectively, involved in
gene fusion events.
Bioinformatics analysis of public transcriptome
sequences in the GenBank also provides ample cases
of fusion transcript candidates. Fusion genes may be
classiﬁed into two groups, interchromosomal and
intrachromosomal. The former results from fusion
between two diﬀerent chromosomes i.e. translocation
and the latter originates from single chromosomes due
to deletion, inversion or ampliﬁcation of large DNA
segments. Romani et al. (16) analyzed the mRNA
sequences and Hahn et al. (17) analyzed the mRNA and
EST sequences to identify fusion transcripts between dif-
ferent chromosomes. Similar data-mining approaches
were adopted to construct databases of fusion genes
such as ChimerDB (18), HybridDB (19) and TICdb (20)
although computational details vary considerably.
ChimerDB is designed to be a knowledgebase of fusion
genes that encompass the fusion transcripts identiﬁed
from bioinformatics analysis of transcript sequences in
the GenBank and various public resources such as the
Sanger CGP (3), OMIM (21), Mitelman’s database (1)
and PubMed. The updated version, ChimerDB 2.0,
features (i) algorithm modiﬁcations for increased sensitiv-
ity, (ii) extensive coverage of recent publications and
relevant databases, (iii) analysis of NGS data in the
NCBI’s short read archives (SRA) and (iv) the enhanced
user interface and the novel alignment viewer to support
diverse types of search. ChimerDB 2.0 would be the most
extensive catalog of fusion genes and transcripts publically
available to date.
IMPLEMENTATIONS
Computational method for transcriptome analysis
The basic strategy is virtually identical to the proce-
dure used in ChimerDB 1.0 where the genomic align-
ments of transcript sequences were analyzed to identify
the fusion transcripts. We will describe the major
diﬀerences and modiﬁcations here with more details
provided in the Supplementary data and in the web site
documentation.
The most important change is relieving the boundary
conditions based on our observation that many reported
cases did not satisfy the strict condition that the fusion
boundary of the transcript should match the exon
boundary. Therefore, we introduced the ‘reliability class’
as a measure of conﬁdence level. We consider the align-
ment with multiple exons or single exon with matching
boundaries as features of reliability. Entry to Class A
requires that both head and tail transcripts consist of
multiple exons or of single exons with matching
boundaries, thus being the most reliable cases. Only one
or neither of the head and tail genes satisfying this condi-
tion would put a given transcript in Class B or C,
respectively.
Another important diﬀerence is the introduction of
various reﬁnement steps. For example, we removed the
entries whose genomic alignments have many hits of com-
parable qualities in diﬀerent genomic regions even though
these genomic regions are not marked as repeat sequences.
This step was necessary to avoid possible complica-
tions arising from gene duplication, pseudo-genes and
retroposon sequences. In addition, the number of exons
was estimated by using the Exonerate program rather than
the BLAT alignments (22,23).
The computational pipeline for 454 sequences from the
SRA is identical with the EST processing since the
sequence length is comparable. Solexa reads are generally
too short and we used them just as supporting evidence for
the existence of fusion transcripts. Solexa transcriptome
reads were aligned using the BWA program (24) against
the fusion transcripts to determine if multiple reads cover
the fusion point. The alignment of resulting candidates
was manually examined.
In this updated version, we also include the fusion
transcripts within the same chromosome. The head and
tails genes, not being adjacent, should be separated by
>1Mb. We exclude the fusion cases between adjacent
genes, which we named co-transcription and intergenic
splicing, in order to limit our focus to genuine fusion
genes originating from chromosomal aberrations.
Data sources
Transcript sequences were downloaded from the GenBank
last updated on September, 2008. It included 323914
mRNA and over 8million EST sequences for human.
We also downloaded NGS transcriptome sequences in
the SRA that included 1.2million 454 sequences and
762million Solexa reads. The human genome map
used for transcriptome analysis was the NCBI build 36.1
(hg18 in the UCSC genome browser database) (25).
Literature-related information was obtained as follows.
PubMed articles related to fusion genes were retrieved by
using the Entrez query of ‘chromosomal translocation or
fusion gene’ and the MeSH terms on human cancers.
Abstracts of 3618 articles were manually examined to
obtain information on the fusion gene pairs. OMIM
records retrieved by the query of ‘translocation or fusion’
(May 2009) were also manually examined to ﬁnd fusion
gene pairs. As for the Sanger CGP data, the ‘cancer
gene census’ list released on December 2008
was downloaded from the web site. Mitelman’s database
was obtained from the web site for the recurrent chro-
mosome aberrations in cancer (http://cgap.nci.nih
.gov/Chromosomes/RecurrentAberrations) as of April
2009. Entries with speciﬁc gene symbols for both head
and tail genes were retained as part of our literature-
related data.
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ChimerDB 2.0 includes 9358 genes, 11747 fusion gene
pairs and 9358 fusion transcripts. Figure 1A shows the
number of fusion gene pairs according to the information
source, counting just the Class A candidates for the
transcriptome analysis. As expected, transcriptome
analysis is the most ample source of fusion gene pairs
and includes 2699 candidates, compared with 300
candidates with the original version. Only 96 cases of
those have the literature evidence from other resources,
implying that the majority of candidates remain to be
veriﬁed experimentally.
Comparison between databases for just the literature-
based cases is also revealing (Figure 1B). The overlaps
between Sanger CGP, OMIM, Mitelman’s database and
our own PubMed collections are much smaller than
expected, and 327 cases out of 556 fusion gene pairs are
found only in one of the literature databases. This reveals
the incomplete coverage of manual eﬀorts and the neces-
sity for integration of various databases. ChimerDB 2.0
includes 537 genes and 556 fusion gene pairs from litera-
ture publications, which is a signiﬁcant increase than other
single database.
Detailed statistics of transcriptome analysis is shown
in Table 1. We found 1046, 6178 and 2674 fusion trans-
cripts from mRNA, EST and 454 sequences, respectively.
In sum, 89% of the total cases are interchromosomal
fusions.
A signiﬁcant proportion of gene pairs (422) in the Class
A features multiple fusion transcripts, thus indicating
an even higher chance of representing genuine fusion.
We also searched the short reads from the Solexa
transcriptome sequences in the SRA that span the fusion
boundary of our candidates. Notably, 82 fusion
transcripts were found to have multiple short-read
matches. One of these fusions, CRTC1-MAML2, has
been reported to be a frequent feature of mucoepidermoid
carcinoma (26). It is noteworthy that intrachromosomal
events are overrepresented among our fusion transcript
candidates. A close look reveals that a major portion
consists of genes belonging to the same family or of
pseudogenes. It remains to be seen whether they are
from alignment ambiguity or genuine fusion events.
User interface
The user interface of ChimerDB is signiﬁcantly improved
in this updated version. Figure 2 shows the important
features in the user interface. Most importantly, we
support diverse types of search targeting transcripts,
genes, gene pairs, cytobands and tissues. As for the fusion
transcripts, users may choose the reliability class, number
of exons, boundary types for the head and tail genes.
The result page includes the gene pairs, disease infor-
mation, PubMed articles and linkouts to diverse
resources. PubMed articles are displayed with the title
and journal name for user convenience. Except for the
Figure 1. The number of gene pairs in the ChimerDB 2.0 according to the information source.
Table 1. Statistics of transcriptome analysis in ChimerDB 2.0
Class Interchromosomal Intrachromosomal
A A+B A+B+C A A+B A+B+C
No. of transcripts 1900 6073 8833 515 887 1065
mRNA 479 855 900 110 143 146
EST 1247 3972 5397 396 677 781
NGS 174 1246 2536 9 67 138
No. of genes (9358 in total) 2855 6976 8710 703 1276 1543
No. of gene pairs 2209 7362 10639 490 909 1108
With multiple transcripts 278 807 1137 144 220 246
With Solexa evidence 14 14 15 65 67 67
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the alignment picture that includes the gene structure,
domains and repeat sequences. We also provide informa-
tion on tissue and pathology type from the GenBank
records and CGAP (Cancer Genome Anatomy Project)
library data. Links to the UCSC genome browser are
provided to allow users to examine the detailed gene struc-
ture and alignment.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
Figure 2. User interface of ChimerDB 2.0. The search page is designed to support diverse types of search. The ‘search result’ page shows the gene
pairs and the disease-related information in OMIM, Sanger CGP and Mitelman’s database with the title and journal name of PubMed articles.
Clicking ‘more info’ link shows the detailed information on fusion genes and transcripts as seen in the bottom panel. The ‘alignment view’ shows the
hypothetical fusion gene (head gene in blue, tail gene in red) and the candidate fusion transcript (in magenta) along with the UCSC-annotated genes
(exons in black, UTRs in grey). The repeat regions and the Pfam domains are indicated in green and orange colors, respectively. Clicking on the
alignment picture opens a magniﬁed view. The information contents in this ﬁgure are trimmed for brevity.
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